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Dorothy E. Rob<rls 
Race, Gender, and Genetic Technologies: A New 
Reproductive Dystopia? 
I 
n the 1980s, Margaret Atwood, Gena Corea, and other feminists imag­
ined dystopias in which white women's reproduction was valued and 
privileged and the reproduction of women of color was devalued and 
exploited. In The Handmaid's Tale, published in 1985,Atwood envisioned 
the repressive Republic of Gilead, where handmaids were forced to serve 
as breeders for elite men and their infertile wives in order to perpetuate 
the white race, while blacks, as well as handmaids who fuiled to bear 
children, were exiled to toxic colonies (Atwood 1985). That same year, 
in The Mother Machine, Corea predicted that white women would hire 
surrogates of color in reproductive brothels to be implanted with their 
eggs and gestate their babies at low cost (Corea 1985). 
Two decades later, feminist scholars have continued to critique the 
hierarchy that anthropologist Rayna Rapp aptly calls "stratified repro­
duction" by contrasting the opposing relationships of white women and 
women of color to reproduction-assisting technologies (1999, 310). At 
the turn of the twenty-first century, even more advanced reproductive 
technologies that combine assisted conception with genetic selection, or 
reprogenetics, threaten to intensifY this opposition (Roberts 2005; Parens 
and Knowles 2007). With preirnplantation genetic diagnosis (PGD), cli­
nicians can biopsy a single cell from early embryos, diagnose it for the 
chance of having hundreds of genetic conditions, and select for implan­
tation only those embryos at low risk of having these conditions (Rob­
ertson 2003; Spar 2006; Singer 2007). As Reprogeneties, a New Jersey 
genetics laboratory that specializes in·PGD, puts it, this technique allows 
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for the "replacement to rhe patient of those embryos classified by genetic 
diagnosis as normal. "1 
At a time when wealthy white women have access to technologies that 
assist them in having children who not only are genetically related to them 
or their partners but have also been genetically screened, various laws and 
policies discourage women of color from having children at all (Roberts 
1998; Smith 2007). 1\J; Rapp stated at a Radcliffe Institute conference, 
Reproductive Health in the Twenty-first Century, in October 2004, 
"Some women struggle for basic reproductive technologies, like a clinic 
where sterile conditions might be. available to perform C-sections, while 
others tum to cutting·edge genetic techniques" (quoted in Drexler 2005 ). 
African American studies scholar Marsha Darling similarly writes, "This 
stunning array of biotechnology is being directed at developing eugenical 
population control strategies especially for low-income and poor women 
of color globally," while "reproduction enhancement options under the 
rubric of 'choice'" are reserved "for economically and racially privileged 
women in the global North" (2004b ). 
While welf.tre reform laws aim to deter women receiving public assis­
tance from having even one adclitional healthy baby (Mink 2002; Smith 
2007), largely unregulated fertility clinics (Arons 2007, 1; Parens and 
Knowles 2007) regularly implant privileged women with multiple em· 
bryos, knowing the high risk multiple births pose for premature delivery 
and low birth weight (Helmerhorst et a!. 2004; Mundy 2007; Reddy et 
al. 2007). The public begrudges poor mothers a meager increase in ben­
efits for one more cltild, but it celebrates the birth of high-tech septuplet.< 
that require a fortune in publicly supported hospital care (Andrews 1999, 
55-61). The multibillion-dollar apparatus devoted to technologically fu,­
cilitating affluent couples' procreative decisions stands in glaring contrast 
to the high rate of infant death among black people, whicb remains more 
than twice the rate for whites (Mathews and MacDorman 2007). Indeed, 
the infant mortality rate is climbing in Mississippi and other southern 
states (Eckholm 2007). 
My prior writing on this reproductive caste system also contrasted pol· 
ides that penalize poor blaek women's childbearing with the high-tech 
fertility industry that promotes childbearing by more affluent whit< 
women (Roberts 1998, 246-93). I recently reconsidered the positioning 
of white women and women of color in the reproductive hierarchy, how· 
ever (Roberts 2005 ). Rather than place these women in opposition, I tied 
them together in relation to the neoliberal trend toward privatization and 
1 See the Reprogc:netics Web site at http:/ /www.rcprogenetics.com/defuult.hunl. 
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punitive governance. Both population control programs and genetic se­
lection technologies reinforce biological explanations for social problems 
and place reproductive responsibility on women, thus privatizing remedies 
for illness and social inequity. 
Population control ideology attributes social inequities to childbearing 
by poor women of color, thereby legitimizing punitive regulation of these 
women's reproductive decisions (Roberts 1998). Stereotypes of black fe­
male sexual and reproductive irresponsibility support welfare reform and 
law enforcement policies that severely regulate poor black women's sexual 
and childbearing decisions (Neubeck 2001). By identifYing procreation 
as the cause of deplorable social conditions, reproductive punishments 
divert attention away from state responsibility and the need for social 
change. Black mothers' crack use, for example, became a primary expla­
nation for high rates of black infant mortality, although this disparity long 
predated the crack epidemic (Roberts 1998, 154-59; Zerai and Banks 
2002; McCaughey 2005 ). 
Like punishments for poor women's childbearing, reprogenetics also 
shifts responsibility for promoting well-being from the government to the 
individual by malting women responsible for ensuring the genetic fitness 
of their children. The individual woman becomes the site of governance 
through self-regulation of genetic risk (Mykitiuk 2000). The medical 
model of disability that promotes eugenic elimination of genetic risk in­
stead of ending discrimination against disabled people supports state re­
liance on individuals to secure their own well-being through the use of 
genetic technologies. This diversion of attention away from social causes 
and solutions reinforces privatization, the hallmark of a neoliberal state 
that seeks to reduce social welfare programs while promoting the free 
market conditions conducive to capital accumulation. Thus, reproductive 
health policies involving women at opposite ends of the reproductive 
hierarchy play an important role in the neoliberal state's transfer of services 
from the welfare state to the private {ealm of furnily and market. 
In the last several years, while working on a book project exploring 
the growth of biotechnologies that incorporate race as a genetic category, 
I have come to reconsider once again the opposition of white women and 
women of color in the reproductive caste system in relation to reproductive 
technologies. The position I just described, like the 1980s reproductive 
dystopias, still casts white women as the only consumers of reproductive 
technologies and women of color only as victims of population control 
policies. It assumes that white women are the only ones with access to 
these technologies and that women of color play no part in the politics 
of reprogenetics, except by their exclusion or exploitation. 
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The recent expansion of both reproductive genetic screening and race­
based biomedicine, however, signals a dramatic change in the racial politics 
of reproductive technologies. First, the important role of genetic screen­
ing, which makes individual citizens responsible for ensuring good health 
by reducing genetic risk, may support the wider incorporation of repro­
genetic technologies into the neoliberal health care system. Second, com­
panies that market race-based biotechnologies now promise to extend the 
benefits of genetic research to people of color (Bloche 2004; Kahn 2007). 
Media promoting genetic technologies prominently feature people of 
color in images representing the new genetic age, in contrast to prior 
portrayals that emphasized whitene
"
ss as the exclusive standard of genetic 
fi.tness.2 Moreover, some clinics that offer high-tech reproductive services, 
including PGD, explicitly appeal to clients of color.' Women of color are 
now part of the market and cultural imaginary of the new reprogenetics. 
We need a new reproductive dystopia that accounts fur the changing racial 
politics of genetics and reproduction. 
In this article, I critically explore the role of race and racism in the 
emergence of reproductive technologies that incorporate advances in ge­
netic science. W hat are the implications of including women of color in 
the market for reprogenetic technologies, particularly when this is done 
with the expectation that women will use these technologies to manage 
genetic risk/ In investigating this question, I hope to shed light on the 
critical relationship between racism, neoliberalism, and reproduction. 
Expanding the market for reproductive technologies 
In Killing the Black Body, I discussed the role of race in images promoting 
the fertility industry (Roberts 1998, 251). I pointed out that pictures 
shmving the success of reproduction-assisting technologies were alway< 
of white babies, usually with blond hair and blue eyes, as if to highlight 
their racial purity. When the New York Times launched a prominent fOur­
article series called "The Fertility Market" in January 1996, for example, 
the front page displayed a photograph of the director of a fertility clinic 
surrounded by seven white children conceived tbere (Gabriel 1996, Al). 
:z. See the Web sites of DNA Tribes (http:/ /www.dnatribes.com}, Gene Tree (http:// 
www.generree.com), and National Geographic's Genographic Project (https:/ /www3 
.nationalgeographk.com/genographic/index.html). 
a See the Pacific Fertility Center's appeal to prospective donors at http:/ Jwww 
.donatcyoureggs.com and information about egg donation at http:/ jwww.pacifu:fertilityanter 
.com/treat/agency_donation.php. 
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The continuing page contained a picture of a set of beaming in vitro 
fertilization (IVF) triplets, also white (Gabriel 1996, A18). 
. In the 1990s, the only time black babies figured in media coverage of 
these technologies -was in stories intended to evoke revulsion precisely 
because of their race. One instance was a highly publicized lawsuit brought 
by a white woman against a ferriliry clinic she claimed had mistakenly 
inseminated her with a black man's sperm, resulting in the birth of a 
mixed-race child (Schatz 1990; Sullivan 1990). Two reporters covering 
the story speculated that "if the suit goes to trial, a jury could be faced 
with the difficult task of deciding damages involved in raising an interracial 
child" (Kantrowitz and Kaplan 1990). The perceived harm to the mother 
of receiving the wrong sperm was intensified by the clinic's fuilure to 
deliver a white baby. 
Other notorious news stories from the 1990s included the case·of twin 
boys born to a white Dutch couple who discovered when the babies were 
two months old that one was white and one was black (Elliot and Endt 
1995). The ferriliry clinic had fertilized the mother's eggs with sperm 
from both her white husband and a black man. A landmark California 
dispute from 1993, Johnson v. Calvert, involved a black gestational "sur­
rogate," Aona Johoson, who was denied any rights to the child she bore 
for the genetic parents, a white man and his Filipina wife, Mark and 
Crispina Calvert! The press paid far more attention to Aona Johnson's 
race than to that of Crispina Calvert. It also portrayed the baby as white. 
By relying on the Calverts' genetic tie to the child to determine legal par­
enthood, the California courts ensured that a black woman would not be 
considered the natural mother of a white child (Roberts 1998, 280-81). 
While the stories involving whites portrayed the positive potential of new 
reproductive technologies, the stories involving women and childr�n of 
color revealed their potential horror. 
Today, however, the high-tech ferriliry business, including genetic­
.screening services, no longer appeals. to an exclusively white clientele. 
Although fertiliry clinics perform sex selection for a range of clients, the 
controversy surrounding this service has centered on Chinese and Indian 
women (Darnovsky 2004; Bumgarner 2007). Images on fertiliry clinic 
'Web sites routinely show people of color alongside claims advertising clinic 
services and their benefits. To be sure, pictures of white babies continue 
to dominate. some Web sites. The home page of the Rinehart Center for 
Reproductive Medicine in Illinois displays the head of a blond-haired baby 
4 Johnson v. Calvert, 5 Cal. 4th 84, 19 Cal. Rptr. 494 (1993), cert. denied, 114 S. Ct. 
206 (1993). 
788 Roberts 
emerging like the sun from billowing white clouds to illustrate its promise 
of "turning your dreams of starting a family into reality."' Sher Institutes 
for Reproductive Medicine, with nationwide locations, streams photo 
strips of its "success stories," showing dozens of children, all of whom 
appear to be white.• 
Similarly, a full-page advertisement for the Virginia-based Genetics and 
IVF Institute, whieh recently appeared in the New York Times Magazine, 
features a giant photo (taking up about half the space) of a white baby 
with blonde hair, blue eyes, and rosy cheeks.' The headline asks, "Over 
40 and thinking of having a baby?" followed by the solution: "DONOR 
EGG Immediate Availability." In the text below, the company boasts of 
offering "Doctoral Donors with advanced degrees and numerous other 
donors with special accomplishments and talents." The assumption that 
whiteness, intelligence, and talent are connected and hereditary remains 
robust in the reprogenetic marketplace. 
Nevertheless, the images associated with reproductive technologies 
have dramatically diversified in recent years. Reproductive Health Spe­
cialists in Illinois displays a photograph of a large group of white couples 
holding white babies, captioned "Baby Picnic. "8 But its Web site also 
contains a photograph of a smiling black man and woman and a drawing 
of a pregnant black woman attended to by a black male partner and female 
physician. Likewise, Houston IVF's Web site shows a beaming black cou­
ple holding a black baby9 The Illinois-based Karande and Associates takes 
a very multicultural approaeh, using a photo of a pregnant East Asian 
woman for scheduling an appointment, a black woman and child for its 
link to donor egg information, and a South Asian man and child for the 
insurance information link. 10 
There are numerous advertisements on craigslist.com explicitly solic-
' See the runehart Center for Reproductive Medicine Web site at http://www 
.illinoisivf.corn. 
6 See the Sher Institutes for Reproductive Medicine Web site at http:/ jwww.Mveababy 
.com/ss/index_ss.cfin? &city= local &site = ss2. 
? See Genetics and IVF Institute, advertisement, New York Times MtVJ4zine, July 29, 
2007,21. 
1 See images of the "baby picnic" at http:/ fwww.reproductivespecialist.com/baby_parties 
.htm. 
9 See rhe Houston IVF Web site at http:/ /Mvw.housronivt:netjhoustonivfjOurScrvkes/ 
OurServices.asp. 
HI For images from the Karande and Associates Web site, see http:/ /www.ka.randei\f 
.com/appointment.html, http'/ jwww.karandeivf.com/eggdonorprogram.html, and http:// 
www.karandeivf.oomfinsurance.html. 
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iring egg donors of color. For example, a posting by Beverly Hills Egg 
Donation notes, "ALL ETHNICITIES WELCOME! "11 F. Williams Donor Ser­
vices' listing states, "Ethnic Diverse Egg Donors Needed" and includes 
a photo of an Asian, a white, and a black woman.12 Happy Beginnings, 
LLC, advertises, "EGG DONORS WANTED ALL ETIINIC BACKGROUNDS," 
specifYing, "WE HAVE A VERY HIGH DEMAND FOR JEWISH, EAST INDIAN, 
MIDDLE EASTERN, ASIAN, ITALIAN, AND BLONDE DONORS. "13 Similarly, 
Pacific Fertility Center boasts that it "maintains a diverse egg donor da­
tabase including Jewish egg donors, Asian egg donors, and a variety of 
backgrounds and ethnidries. "14 
Some fertility clinic Web sites not only market their reprogenetic ser­
vices to people of color, but they also perform race-based genetic testing 
as part of those services. Pacific Fertility Center's Web site includes the 
statement, "Genetic screening is also recommended, based on ethnic back­
ground.'ns 
Reproductive Genetics Institute in Chicago similarly includes race in 
the factors it takes into account in its genetic testing: "Screening Results 
and Accuracy: By combining the results of the ultrasound and blood test 
along with the age, race and weight of the mother, a number can be 
generated by computer which represents the risk of the pregnancy being 
affected by Down syndrome or another chromosome problem. Experience 
has shown that, together, the ultrasound and blood screen will identify 
approximately 90% of babies with chromosome abnormalities. "16 
Fertility clinics' use of race in generic selection procedures may help 
to reinforce the erroneous belief that race is a biological classification that 
can be determined generically or that generic traits occur in human beings 
according to their race. Social scientists' demonstration that race is an 
invented social grouping was confirmed by genomic studies of human 
variation, including the Human Genome Project, showing high levels of 
11 See Beverly Hills Egg Donation, advertise�ent, Los Angeles craigslist.com, SF Valley, 
etcetera jobs, November 22, 2008. 
12 See F. Williams Donor Services, advertisement, Inland Empire craigslist.com, etcetera 
jobs, November 24, 2008. 
13 See Happy Beginnings, LLC, advertisement, Reno craigslist.com, etcetera jobs, No­
vember 13, 2008. 
14 See the Pacific Fertility Center's appeal to prospective donors at http://www 
.donateyoureggs.com. 
15 See the Pacific Fertility Center's Web site at http:/ /www.pacificfertilitycenter.com/ 
treat/agency_donation.php. 
16 See the Reproductive Genetics Institute's Web page on first trimester screening at 
http:/ /www.reproductivegenetics.com/firsLtrimester.html. 
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genetic similarity among people of all races (Graves 2001; Cooper, Kauf­
man, and Ward 2003 ). At the onset of the Human Genome Project, some 
scholars believed that the science of human genetic diversity would replace 
race as the preeminent means of grouping people for scientific purposes 
(Lewontin 1995;
. 
Reardon 2005). Yet the use of race as a biological cat­
egory in generic research and biotechnology is intensifYing (Burchard et 
al. 2003; Bonham, Warshauer-Baker, and Collins 2005; Duster 2005). 
The marketing of higb-tech reproductive services to women of color 
is part of a broader inclusion of minority groups in the testing and pro­
duction of cutting-edge biotechnologies. In June 2005, the Food and 
Drug Administration (FDA) approved the first race-based pharmaceutical, 
BiDil, to treat heart failure specifically in African American patients (Saul 
2005 ). BiDil is the combination of two generic drugs that doctors were 
already prescribing regardless of race. Yet the FDA permitted its maker, 
Nitromed, to market BiDil as a drug for black people. Making BiDil race 
specific also allowed Nitromed to extend its patent to the year 2020, 
giving the company market exclusivity and the potential to reap huge 
profits on drug sales (Kahn 2004 ). The manufacturer's unproven theory 
supporting the need for a race-specific therapy is that the reason for higher 
mortality rates among black heart patients lies in genetic differences 
among "races,,, in either the reason for getting heart disease or the reason 
for responding differently to medications for it (Kahn 2004; Sankar and 
Kahn 2005). 
BiDil is only one example of the growing trend toward "the strategic 
use of race as a genetic category to obtain patent protection and drug 
approval" (Kahn 2006, 1349). In his survey of gene-related patent ap­
plications, legal scholar Jonathan Kahn discovered that the use of race has 
increased fivefold in the past twenty years (2006). Claims about justice 
in scientific research have shifted away from protecting socially disadvan­
taged subjects from unethical practices and toward promoting access to 
clinical trials and biotech products (Epstein 2007). There is strong support 
for racial therapeutics among some black advocates, researchers, and phy­
sicians precisely to redress past discrimination and fulfill long-standing 
demands for science to attend to the health needs of African Americans 
(Puckrcin 2006; see Roberts 2008). This increased commercial and pop­
ular demand for race-specific pharmaceuticals threatens to reinforce a fulse 
belief in the biological origin of race. . 
Advanced reproductive technologies similarly constitute a form of race­
based medicine. Rather than serve an exclusively white clientele, fertility 
clinics are marketing genetic technologies to women of color on the basis 
of race and ethnicity and incorporating race in genetic-screening proce-
I 
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dures. Contemporary reproductive dystopias, then, should not categori­
cally exclude women of color from their imagined users of genetic selection 
technologies. As I explain below, the expansion of race-based biotech­
·nology, including genetic selection, fits within the neoliberal trend toward 
privatization and punitive governance and requires adjusting feminist re­
productive dystopias. 
Neoliberalism and reproductive dystopia 
The marketing of reprogenetics to women of color is taking place in the 
conte:<t of neoliberal shifts in governance that may encourage the expan­
sion of genetic-screening technologies to a broader clientele. Widespread 
prenatal testing has already generated greater surveillance of pregnant 
women and assigned them primary responsibility for making the "right" 
genetic decisions. It is increasingly routine for pregnant women to get 
prenatal diagnoses for certain genetic conditions such as Down syndrome 
or dwarfism (Powell 2007; Saxton 2007). It is also often expected that 
they will opt for abortion to select against any disabling traits identified 
by genetic testing. Many obstetricians provide these tests without much 
explanation or deliberatiou because they consider such screenings to be 
a normal part of treating their pregnant patients. The director of repro­
ductive genetics at a large Detroit hospital reported that at least half of 
the women referred there with an abnormal amniocentesis result were 
"uncertain about why they even had the test" (Consumers Union 1990, 
486). Moreover, current tort case law creates incentives in favor of genetic 
testing by imposing legal duties on obstetricians to offer it (Wei! 2006, 
52; Ossorio 2007, 330). Wbile there are virtually no legal consequences 
for doctors who encourage genetic tests, doctors who fail to use them 
may be liable for damages in "wrongful birth" lawsuits.17 
Although genetic counseling should be nondirective, many counselors 
show disapproval when patients decid� against selective abortion. A ge­
netic counselor asked a woman who decided to bear a child with Down 
syndrome, "Wbat are you going to say to people when they ask you how 
you could bring a child like this into the world/" (quoted in Helm, Mir-
1' For example, the Supreme Court of Ohio recently held that parents of an unhealthy 
child born following negligent failure to diagnose a fetal defect or.disease may bring suit 
under traditionaJ medical malpractice principles for the costs arising from the pregnancy and 
birth of the child: &hirmer P: Mt. Auburn Dbstctria and Gynecologic A.tsociatts1 Inc., 108 
Ohio St. 3d 494, 2006-0hio-942 (Ohio S. Ct. 2006). For an argument in favor of using 
tort law to compensate for "procreative injury" caused by reproduction assisting technologies, 
see Kleinfeld (2005). 
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anda, and Chedd 1998, 59). Brian Skotko's survey of985 mothers who 
received postnatal diagnoses of Down syndrome for their children similarly 
discovered that many of the mothers were chastised by health care pro­
fessionals for not ':"'dergoing prenatal testing: 
"Right after [my child] was born, the doctor flat out told my hus­
band that this could have been prevented or discontinued at an 
earlier stage of the pregnancy," wrote one mother who had a child 
with DS in 2000. A mother who had a child in 1993 recalled, "I 
had a resident in the recovery room when I learned that my daughter 
had DS. When I started to cry, "I overheard him say, 'What did she 
expect? She refused prenatal testing.'" . . . Another mother re­
ported, from her experience in 1997, "The attending neonatologist, 
rather than extending some form of compassion, lambasted us for 
our ignorance in not doing prior testing and for bringing this burden 
to society-noting the economical, educational, aQ.d social hardships 
he would bring." Regarding a postnatal visit, a mother who had a 
child in 1992 wrote, "[My doctor] stressed 'next time' the need for 
amniocentesis so that I could 'choose to terminate."' (2005, 70-71) 
As a result of such pressure, many pregnant women now view genetic 
testing as a requirement of responsible mothering (Harmon 2007). 
Poor women, especially women of color, currently face financial and 
other barriers to receiving high-tech infertility services (Elster 2005). Be­
cause genetic screening is now considered an essential part of preventive 
medicine, however, these technologies are becoming integrated into social 
welfare systems and private insurance schemes and are likely to become 
increasingly available to poor and low-income women (Van den Daele 
2006; Bumiller 2009).18 Unlike IVF, whose primary purpose is to increase 
fertility, PGD functions to help women avoid starting a pregnancy that 
entails disfuvored genetic traits (Franklin and Roberts 2006, xx, 97).19 
The ain1 of IVF is to produce the birth of a live baby; the aim of PGD 
and fetal diagnosis is to prevent the birth of certain children. While gov­
ernment welfare systems have disdained fucilitating childbearing by poor 
women of color by declining to fund fertility treatnlents, they may there­
fore treat genetic testing differently. 
111 Foe an extensive review of insurance coverage ofinfertility treatments, sec Aeons {2007, 
8-13): "Fourteen states currendy require some types of health insurance plans to include 
coverage of certain infertility services or to make such coverage available" (8). 
111 PGD also serves to increase fertility when it is undertaken to improve IVF success 
rates (Franklin and Roberts 2006, 97). 
,. 
l 
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'The current ban on federal funding of abortion places a significant limit 
on state genetic selection programs (Powell 2007, 49-50). In states that 
do not provide Medicaid funding for abortion, poor women can receive 
sta te-sponsor ed genetic te sti ng but have to pay for the cost of sel ec tiv e 
abortions themselves. Yet it is not hard to foresee future federal and state 
legislation that exempts "therapeutic" abortions based on genetic testing 
from the ban on abortion funding. Prior to the 1973 passage of Roe v. 
Wade, upholding the constitutional right to abortion, many states per­
mitted therapeutic abortions recommended by physicians while criminal­
izing elective abortions sought by women with unwanted pregnancies 
(Schoen 2005, 153-86). 
Indeed, some clients of reprogenetics have claimed moral superiority 
over women who have had abortions for nonselective reasons. In a July 
22, 2004, op-ed piece in the New York Times, Barbara Ehrenreich calls 
on women who had aborted fetuses based on prenatal diagnosis to support 
the general right to abortion (2004). She notes that these women some­
times distinguish themselves from women who have "ordinary" abortions. 
One woman who aborted a fetus with Down syndrome states, "I don't 
look at it as though I had an abortion, even though that is technically 
what it is. There's a difference. I wanted this baby" (quoted in Ehrenreich 
2004, A21). On a Web site for a support group called "A Heart breaking 
Choice" a mother who went to an abortion clinic complains, "I r esent ed 
the fact that I had to be there with all these girls that did not want their 
babies" (quoted in Ehrenreich 2004, A2l ). The incorporation of eugenic 
values in arguments for women's reproductive freedom neglects the his­
tory of abortion regulation, which limited women's reproductive freedom 
by distinguishing between approved therapeutic and disapproved elective 
abortions. An attempt to solicit supporters of selective abortion to join 
the cause of abortion rights misunderstands the nature of reproductive 
politics in the neoliberal age. 
The expansion of genetic research apd technologies has helped to create 
a new biological citizenship that enlists patients to take unprecedented 
authority over their health at the molecular level (Rose 2007). According 
to British sociologist Nikolas Rose, "our very biological life itself has 
e nre red the doniain of decision and choice" (2007, 40). Some scholars 
have highlighted the enhancement of human agency, as "patients are in­
creasingly urged to become active and responsible consumers of medical 
services and products ranging from pharmaceuticals to reproductive tech­
nologies and genetic tests" (2007, 4) and to form alliances with physicians, 
scientists, and clinicians to advocate for their interests (Franklin and Rob­
erts 2006, xvii). 
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Biological citizenship also reflects the shift of responsibility for public 
welfare from the state to the private realms of market and family. As Rose 
observes, responsibility for the management of health and reproduction 
has devolved from the "formal apparatus of the government" to "quasi­
autonomous regulatory bodies', such as bioethics commissions, profes­
sional groups, and private corporations (2007, 3). Selling genetic testing 
products directly to consumers is big business for private fertility clinics 
and biotechnology companies. Biomedical research and technology have 
correspondingly become major sources of capital accumulation, aided by 
federal patents on genetic information, FDA approval of pharmaceuticals, 
and public funding of lucrative private research ventures, such as Cali­
fornia's stem cell research initiative. 
In this neoliberal context, genetic testing serves as a form of privati­
zation that makes the individual the site of governance through the self­
regulation of genetic risk (Mykitiuk 2000). Reproductive genetic tech­
nologies, in particular, introduce a new gendered division of labor and 
surveillance as women bear the brunt of reprogenetics' contribution to 
the neoliberal restructuring of health care (Mykitiuk 2000). Canadian legal 
scholar Roxanne Mykitiuk points out that, contrary to the deregulation 
that typically occurs in the service of big business, the new duties imposed 
on women constitute a reregulation that supports capital investment in 
market-based approaches to health care and other social needs while state 
investment in public resources shrinks (2000). 
In addition, reprogenetics incorporates a seemingly benign form of 
eugenic thinking in its reliance on reproductive strategies to eliminate , 
genetic risk rather than social strategies to eliminate systemic inequities. � 
Some disability rights advocates oppose prenatal genetic diagnosis that 
leads to discarding embryos and fetuses predicted to have disabilities be- � 
cause these procedures devalue people who have disabilities, sending the 
message that they should never have been born (Wendell1996, 151-56; 
Parens andAsch 2007; Saxton 2007). They argue that although disabilities 
cause various degrees of impairment, the main difficulty in having a dis­
ability stems from pervasive discrimination. "Rather than improving the 
medical or social situation of today's and tomorrow's disabled citizens," 
write bioethicists Erik Parens and Adrienne Asch, "prenatal diagnosis re­
inforces the medical model that disability itself, not societal discrimination 
against people with disabilities, is the problem to be solved" (2007, 13). 
The reasons why some parents do not want a disabled child are varied. 
Wbilo some women may use genetic selection in an upwardly mobile quest 
for the "perfect child," others want to prevent their children from suffering 
the pain, illness, and physical limitations that accompany disabilities or 
5 I G N 5 S&rmmer 2009 795 
worry that they are not capable of dealing with rlisability's social conse­
quences (Wendell 1996, 82-83; Franklin and Roberts 2006, 132-62; 
Baily 2007). Yet given merlical professionals' implicit rlirective favoring 
genetic selection and powerful stereotypes that negatively depict disabled 
people, many women are left with a false impression of the nature of 
parenting a disabled child and the quality of disabled people's lives (which 
· genetic testing cannot predict; Bumiller 2009). Pregnant women are rarely 
able to make truly informed decisions about what to do with test results 
because they, obstetricians, and counselors typically have little information 
about the lives of disabled people and their f.unilies (Wendell1996, 81-84; 
Parens and Asch 2007, 33-37).20 
Moreover, some of the undesirable events likely to happen to a child 
with a serious disability that parents may reasonably wish to prevent, such 
as limited educational and employment opportunities, are caused by social 
as much as physical impediments (Steinbock 2007, 119). Unable to count 
on societal acceptance or support, many women feel compelled to turn 
to genetic testing to ensure their children's welfare (Lippman 1991, 39; 
Kittay 2007, 181 ). With'out judging the morality of individual women's 
decisions, we must critically evaluate the social, political, and legal incen­
tives for genetic testing as well as consequences of genetic testing for 
people with disabilities. Building on the disability critique, we must also 
question the role that the eugenic approach to disability plays in neoliberal 
governance. 
Rose, the British sociologist discussed above, rejects critical intellec­
tuals' use of eugenics rhetoric to contest PGD and other aspects of con­
temporary biological politics (2007, 54-68). He argues that the eugenics 
practiced in the first half of the twentieth century was a particular bio­
political strategy that sought to improve the population as a whole through 
deliberate state action. This effort "to control the biological makeup of 
the population" as a whole, he claims, rlistinguishes eugenics from the 
new biopolitics' concern with the genetic health of individuals (2007, 56). 
"What we have here, then, is not eugellics but is shaped by forms of self­
government imposed by obligations of choice, the desire for self-fulfill­
ment, and the wish of parents for the best Jives for their children," Rose 
concludes (2007, 69). 
Rose dismisses the relevance of eugenics to contemporary biopolitics 
�o A recent survey of research on the experience of disability in families concluded, "There 
is an increasingly dominant body of research that finds aggregate patterns of overall adjust­
ment and well-being to be similar across groups of families with and without children with 
disabilities" (Ferguson, Gartner, and Lipsky 2007, 85). 
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too categorically. He downplays eritical aspects of the past eugenics regime 
that characterize both contemporary population control policies and ge­
netic-screening technologies such as PGD. By eugenic thinking or values, 
I refer to the belief that reproductive strategies can improve society by 
reducing the births of socially marginalized people. The eugenic approach 
to social problems locates them in reproduction rather than social structure 
and therefore seeks to solve them by eliminating disfuvored people instead 
of social inequities. Its chief epistemological device is to make the social 
order seem natural by casting its features as biological facts. As Donald 
MacKenzie observes, eugenic theory is "a way of reading the structure 
of social classes onto nature" (1981; 18). Programs based on such a belief 
set up standards for reproduction that subsume childbearing under pre­
vailing hierarchies of power. 
Eugenics did not function only "in the service of a biological struggle 
between nation-states" (Rose 2007, 66); it functioned to maintain the 
racial, gender, and class order 'vithin the nation. (Moreover, alliances / 
between American and Nazi eugenicists in the 1930s show a \villingness ' 
to cross national boundaries in the interest of white supremacy. )21 Thus, 
contemporary proposals to solve social problems by curbing black repro­
duction, such as the Philadelphia Inquirers suggestion to distribute the 
long-acting contraceptive Norplanc as a remedy for black poverty, are 
similar to past eugenic policies in that they make racial inequality appear 
to be the product of nature rather than power (Kimelman 1990). By 
identifYing procreation as the cause of black people's condition, they divert 
attention away from the political, social, and economic forces that maintain 
the U.S. racial order. I therefore believe it is accurate and helpful to identity 
the ways in which contemporary reproductive health policies incorporate 
essential features of eugenic ideology, despite the important differences 
that Rose highlights. 
Futhermore, the distinction between past state-imposed and current 
voluntary programs is not as clear-cut as Rose suggests. On the one hand, 
Rose ignores the system of punitive governance that accompanies the 
l neoliberal shift to individual self-governance. Welfare is no longer a system , 
of aid but rather a system of behavior modification that attempts to reg- ! 
ulate the sexual, marital, and childbearing decisions of poor unmarried 
mothers by placing conditions on the receipt of state assistance (Roberts 
n When the leading American eugenicist, Harry Laughlin, received an honorary degree 
from the University of Heiddberg in 1936, he wrote to German officials that the award 
represented "evidence of a common understanding of German and American scientists of 
the nature of eugenics" (quoted in Kevles 1985, 118). 
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1998; Mink 2002; Smith 2007). Meanwhile, federal and state govern­
ments aggressively intervene in marginalized communities to manage their 
social deprivation with especially punitive measures. The U.S. prison pop­
ulation has grown to proportions unprecedented in the history of Western 
democracies, as an astounding number of young black men are locked up 
(Garland 2001; the Sentencing Project 2005). The racial disparity in the 
foster care population mirrors that of the prison system, as child protection 
authorities remove grossly disproportionate numbers of black children 
from their homes (Roberts 2002). Population control policies that at­
tribute social inequities to the childbearing of poor minority women are 
a critical component of this punitive trend away from state support for 
fumilies and communities (Roberts 1998; Smith 2007). Rose's reference 
to "the enabling state, the fucilitating state, the state as animator" (2007, 
63) does not apply to policies designed to penalize childbearing by poor 
women and women of color. 
On the other hand, Rose's focus on state direction of twentieth-century 
eugenic programs obscures the crucial role of private enterprises in dis­
seminating and implementing eugenics. Just as influential as the man­
datory sterilization Jaws passed in most states were the campaigns waged 
by private groups such as the American Eugenics Society, the Human 
Betterment Association, and the American Genetics Association to educate 
the American public about the benefits of eugenics, as well as the American 
Birth Control League's programs to distribute birth control to the unfit 
(Kevles 1985). As Rose acknowledges, "Eugenics was not disreputable or 
marginal: it defined one dimension of mainstream thinking about the 
responsibilities of politicians, protessionals, scientists, and inclividuals in 
the modern, world" (2007, 59). 
Some feminists who use eugenics rhetoric to critique modern genetic 
selection technologies explicitly acknowledge the distinction between 
state-imposed programs and private decisions made by individuals. For 
example, U.S. sociologist Barbara Katz Rothman calls the marketing of 
prenatal diagnostic technologies a for� of microeugenics, focused on the 
individual, in contrast to macroeugenics, focused on populations (2001 ). 
I also explicitly distingnish between population control policies and those 
that promote reprogenetics while drawing attention to their common 
support of neoliberal approaches to social inequities (Roberts 2005 ). This 
distinction, however, should not eclipse the coercive .. nature and social 
function of contemporary repro genetics (Wendell1996, 156; Ward 2002). 
As I discuss above, genetic selection procedures are increasingly treated 
as social responsibilities reinforced not only by cultural expectations but 
also by legal penalties and incentives. Does the state-supported repro-
198 Roberts 
ductive genetics industry exist only to give individual citizens more re­
productive choices, or, as Laura Hershey asks, is it uprimarily for rhe 
benefit of a society unwilling to support disability-related needs?" (1994, 
3 1 ;  see also Wendell l996, 154). 
Rose's analysis of contemporary biopolitics helps to illuminate rhc rad­
ical change from state management of the population's healrh to individual 
management of genetic risk, aided by new genetic technologies. These 
technologies facilitate rhe shift from state responsibility for ensuring health 
and welfare to private responsibility, all wirhin the context of persistent 
race, gender, and class inequities; devastating reductions in social pro­
grams; and intense state surveillance of marginalized communities. Ge­
netic screening is increasingly recommended not only to avoid having 
children wirh serious early onset disabilities or diseases wirh a high like­
lihood of occurring but to eliminate rhe risk of developing certain diseases 
as an adult (Obasogie 2006). A recent article in rhe Journal of the Amer­
ican Medical Association, for example, encouraged families affected by 
hereditary cancer syndromes, including breast, ovarian, and colon cancer, 
to use PGD to screen out embryos genetically predisposed to develop 
cancer (Offit, Sagi, and Hurley 2006). In rhe neoliberal future, rhe state 
may rely on rhe expectation that all pregnant women will undergo genetic 
testing to legitimize not only its refusal to support rhe care of disabled 
children but also its denial of broader claims for public provision ofhealrh 
care. 
Extending choice to women of color 
The role reprogenetics plays in neoliberalism's inregrated system of pri­
vatization and punitive governance is obscured by liberal notions of re­
productive choice. Despite rhe potential for reprogenetics to diminish 
public healrh care and intensifY regulation of women's reproductive de­
cisions, its sponsors often defend the industry's immunity from state reg­
ulation in rhe name of women's reproductive freedom (Rorhman 1989, 
116; Darling 2004a). Extending rhe availability of genetic selection tech­
nologies to women of color does not correct rhe role played by repro­
genetics in advancing a neoliberal agenda. Tbe depletion of public re­
sources for general healrh care and for supporting people with disabilities 
would exacerbate economic inequities along racial lines, hitting poor mi­
nority communities rhe hardest. In addition, rhe expectation of genetic 
self-regulation may fall especially harshly on black and Latina women, who 
are stereotypically defined as lacking rhe capacity for self-control. The use 
of high-tech, expensive technologies by a privileged slice of women of 
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color suggests that those who do not use them for financial, social, or 
ethical reasons may be blamed for the social consequences. 
There may always be certain reproductive technologies that are reserved 
for the wealthiest people and are outside the reach of most women of 
color. The market will privilege a tiny elite among people of color who 
can afford high-tech reproductive innovations while relegating the vast 
majority to the state's most intense reproductive surveillance. Indeed, the 
neoliberal reification of market logic is likely to expand the hiring of poor 
and low-income women of color for their reproductive services. The in­
cidence of payments to these women to gestate fetuses or to produce eggs 
for genetic research could intensify (Haworth 2007) even as they are 
encontaged to use genetic technologies to screen their own children. 
In addition, marketing race-based biotechnologies to consumers of 
color can reinforce the biological meaning of race. By incorporating in­
vented racial categories into genetic research, scientists and entrepreneurs 
are producing biotechnologies that validate people's belief that race is a 
natural classification. A renewed trust in inherent racial differences pro­
vides an alternative explanation for persistent gross inequities in blacks' 
health and welfare despite the end of de jure discrimination. These tech­
nologies promote the view that deepening racial inequities that result from 
neoliberal policies are actually caused by genetic differences between 
whites and other racialized groups. The biological explanation for racial 
disparities provides a ready logic for the staggering disenfranchisement of 
people of color through mass incarceration and other punitive policies, 
as well as the perfect complement to color-blind policies implementing 
the claim that racism has ceased to be the cause of their predicament. 
Including women of color in the market for reprogenetic technologies 
does not eradicate the racial caste system underlying reproductive strati­
fication. 
A reproductive dystopia for the twenty-first century could no longer 
exclude women of color from the market for high-tech reprogenetics. 
Rather, it would take place in a society in which racial and economic 
divisions are reinforced by the genetic testing extended to them. In this 
new dystopia, the biological definition of race is stronger than ever, val­
idated by genetic science and cemented in popular culture by race-based 
biotechnologies. The state has disclaimed all responsibility for supporting 
its citizens, placing the duty of ensuring public welfare in all women's 
self-regulation of genetic risk. The medical model of disability is embedded 
in a neoliberal health policy that relies on widespread use of genetic tech­
nologies to disqualifY citizens from claiming public support and to avoid 
the need for social change. The new biologization of race may seem to 
BOO Roberts 
unite blacks, and other nonwhite "races," by confirming the genetic uni­
formity of people belonging to the same race and their genetic difference 
from others. In the new dystopia, however, genetic selection technologies 
that incorporate race as a biological category reinforce class divisions be­
tween elite people of color who can afford the full array of high-tech 
procedures and the masses who snffer most from neoliberal policies bol­
stered by these very biological explanations of racial inequities. But I can 
also imagine a new utopia arising from feminists' radical resistance to 
enlisting women as genetic screeners in service of a neoliberal agenda, a 
resistance that is emboldened by new alliances-joining reproductive jus­
tice with antiracist, disability rights; and economic justice movements that 
recognize their common interest in contesting a race-based reprogeneti.c 
future. 
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